Bioresponsive Immunotherapeutic Materials

Abstract

The human immune system is an interaction network of biological processes, and its dysfunction is closely associated with a wide array of diseases, such as cancer, infectious diseases, tissue damage, and autoimmune diseases. Manipulation of the immune response network in a desired and controlled fashion has been regarded as a promising strategy for maximizing immunotherapeutic efficacy and minimizing side effects. Integration of “smart” bioresponsive materials with immunoactive agents including small molecules, biomacromolecules, and cells can achieve on‐demand release of agents at targeted sites to reduce overdose‐related toxicity and alleviate off‐target effects. This review highlights the design principles of bioresponsive immunotherapeutic materials and discusses the critical roles of controlled release of immunoactive agents from bioresponsive materials in recruiting, housing, and manipulating immune cells for evoking desired immune responses. Challenges and future directions from the perspective of clinical translation are also discussed.

Supramolecular Nano‐Grid Platform to Load and Deliver Liposomes and Exosomes

“…[ 23 ] ROS such as H 2 O 2 exists at low levels in healthy tissues, whereas a sharp rise can occur in tumor or inflamed conditions. [ 24 ] Therefore, microenvironmental changes make it possible for disease‐specific drug delivery in controlled manner. To examine the H 2 O 2 /pH‐dependent degradation behavior of BOF, material was suspended in phosphate‐buffered saline (PBS) with different pH levels or H 2 O 2 concentrations and the transmittance of the suspension was periodically measured at 500 nm.…”

Designing Hydrogels for Immunomodulation in Cancer Therapy and Regenerative Medicine

“…Hydrogel delivery systems can be designed to precisely control the release profiles of multiple bioactive agents and cells for efficient combination immunomodulation. [ 190 ] Triggered release behavior can be achieved by designing hydrogels capable of responding to the abnormal environment characteristics at pathological sites, such as pH, ROS, and ATP.…”

Stimuli-Responsive Polymeric Nanomedicine for Enhanced Cancer Immunotherapy

“…Many enzymes have been reported to facilitate tumor progression and invasion, including cathepsin-B, cathepsin-K, matrix metalloproteinases (MMPs), heparinase, endoglycosidase, and hyaluronidase. , Especially, MMPs play a significant role in modulating the equilibrium between cell adhesion and the proteolytic degradation of the extracellular matrix, thereby contributing to tumor metastasis. To achieve targeted drug release in the TME, nanoparticles designed to respond to MMPs are equipped with specific peptide sequences that effectively interact with MMPs.…”